Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. (Q51552694)

6 April 2018

title

Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. (English)

1 reference

6 April 2018

1 reference

Dujovne CA

1

1 reference

6 April 2018

Harris WS

2

1 reference

6 April 2018

Altman R

3

1 reference

6 April 2018

Overhiser RW

4

1 reference

6 April 2018

Black DM

5

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 February 2000

1 reference

6 April 2018

American Journal of Cardiology

published in

1 reference

6 April 2018

volume

85

1 reference

6 April 2018

issue

3

1 reference

6 April 2018

page(s)

350-353

1 reference

6 April 2018

Hypercoagulability and ischaemic heart disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Lovastatin therapy in hypercholesterolemia: effect on fibrinogen, hemorrheologic parameters, platelet activity, and red blood cell morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

The effect of variable fat diets and cholesterol-lowering drugs on Antithrombin III levels in hyperlipoproteinemic and normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Effect of atorvastatin on plasma fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

[Rapid physiological coagulation method in determination of fibrinogen]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

The effect of urea on red cell deformability during cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

A procedure for the simultaneous determination of lipid and protein in biomembranes and other biological samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Critical evaluation of platelet aggregation in whole human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Lipids and stroke: a paradox resolved

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Assessment of effects of lipid-lowering drugs on hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease: The Caerphilly and Speedwell Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

Influences of lipid-modifying agents on hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900745-6

10.1016/S0002-9149(99)00745-6

7 January 2021

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018